LAVCA VC
  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA
  • Member Login
  • Member Access

LAVCA VC

  • News Feed
  • VC Data
  • Directories
  • Features
  • Tech Growth Coalition
  • LAVCA Gender Diversity
  • Engage
    • VC Council
    • VC Members
  • LAVCA

Physician Group to Sell Minority Stake in Fleury S.A. to Advent International

16 September 2015

(Press Release) A physician group that owns a significant interest in Fleury S.A., the second-largest diagnostic services provider in Brazil, has agreed to sell a minority stake in the Company to Advent International, one of the largest and most experienced global private equity investors.

Under the agreement, Advent will acquire 13% of Fleury; the physician group will retain 28.3% of the Company, and another existing shareholder, Bradesco Seguros (“Bradseg”), will maintain its 16.4% ownership interest. The remaining 42.3% of Fleury will continue to be held by public investors. The transaction, which is subject to closing conditions and is expected to be completed in the fourth quarter of 2015, achieves the physician group’s objective of partnering with a strategic investor for the sustainable development of the Company.

Founded in 1926, Fleury offers a broad range of premium diagnostic services in laboratory medicine, diagnostic imaging, pathology and other medical diagnostic services to hospitals and laboratories across Brazil. The Company is one of the most respected medical and healthcare organizations in the country, recognized for its attentive customer service, innovation and technical quality. In 2014, Fleury served more than eight million patients and performed 54 million tests at its 153 patient service centers nationwide under the Fleury, Weinmann, Felippe Mattoso, a+, Diagnoson a+ and Labs a+ brands. The Company offers approximately 3,500 clinical, pathological and imaging tests in 37 diagnostic areas and medical specialties, including cardiology, gastroenterology, gynecology, maternal-fetal medicine, neurology, urology, genetic counseling, endocrinology and hematology.

“The demand for diagnostic medicine is growing steadily in Brazil as a result of the country’s expanding access to healthcare services, aging population and increasing focus on preventive medicine, and Fleury is strongly positioned to benefit from these trends,” said Juan Pablo Zucchini, a Managing Partner in Advent’s São Paulo office. “We are pleased to have the opportunity to work with the Fleury Board and management team and look forward to applying our global healthcare expertise and local market knowledge to help the Company strengthen its position as an innovative and leading player in the Brazilian healthcare industry.”

Dr. Marcos Bosi Ferraz, Chairman of the Board of Fleury, said, “Healthcare remains a top priority for the Brazilian population as preventive medicine and early diagnosis are becoming increasingly important areas of focus for patients and insurance providers. The physician group and the Fleury Board are pleased to welcome Advent as a new partner as we continue to focus on strengthening Fleury´s capabilities and geographic footprint. Advent has relevant resources and expertise that we believe will help our company achieve its goals.”

“Fleury combines high-quality medical services, a proven track record of growth and a highly motivated management team,” said Carlos Marinelli, CEO of Fleury. “Advent will bring to the partnership its knowledge and investment experience in the healthcare sector, and we look forward to working with them as we focus on leveraging our core brands and innovation to enhance the patient experience and drive additional value for our shareholders.”

Advent is one of the leading private equity investors in Latin America. Since 1996, the firm has invested in 50 companies across the region and fully realized its positions in 33 of those businesses. Advent has been investing in the healthcare industry for more than two decades and has completed 35 investments in the sector across 13 countries worldwide. Recent healthcare investments in Latin America include Biotoscana, a specialty pharmaceutical company with operations throughout the region; United Medical, a Brazilian pharmaceutical company acquired by Biotoscana; and Laboratorio LKM, one of the leading specialty pharmaceutical manufacturers in Argentina.

Inspire Capital Partners and J.P. Morgan served as financial advisors and Machado Meyer served as legal advisor to the physician group. Credit Suisse served as financial advisor and Lobo & de Rizzo Advogados acted as legal advisor to Advent.

Physician Group to Sell Minority Stake in Fleury S.A. to Advent International was last modified: December 8th, 2015 by Editor
Advent InternationalBrazilDiagnostic ServicesGrupo FleuryPharmaceuticals
0
Facebook Twitter Google +

Tech Growth Membership

The 2023 LAVCA Startup Founders Survey is made possible thanks to the support of LAVCA’s Tech Growth Membership, a group of leading tech companies and investors advancing the tech ecosystem in Latin America including AWS, Mercado Libre, Microsoft, Qualcomm Ventures, SVB, Riverwood Capital, Google and Movile.

VC Partner Events

    Tweets

    Missing consumer key - please check your settings in admin > Settings > Twitter Feed Auth

    Submit VC News

    Have private equity or venture capital related news that you would like to share? Submit your press releases and news to [email protected].

    VC Industry News

    • Valor Capital Group Leads USD20m Series B for Mexico’s Nexu

      17 October 2023
    • KASZEK Leads USD16.5m Round for Colombia’s Bia

      9 October 2023
    • Valor Capital Group and NFX Co-Lead USD9.3m Series A for Brazil’s Praso

      30 August 2023
    • EQT Growth Leads USD85m Series F for Brazil’s Gympass at USD2.2b Valuation

      23 August 2023
    • Tiger Global Leads USD61m Series B for Brazil’s Nomad 

      22 August 2023
    • NASZCA and IDB Invest Lead USD15.5m Series A for Mexico’s Wonder Brands

      17 August 2023
    • Victory Park Capital Provides USD100m Credit Facility for Mexico’s Klar

      15 August 2023
    • General Catalyst Lead USD45m Series B for Brazil’s Tractian

      7 August 2023
    • General Catalyst Leads USD45m Round for Brazil’s Tractian

      7 August 2023
    • ADQ Provides USD100m In Convertible Debt to Brazil’s Loft

      2 August 2023

    About LAVCA

     

    LAVCA is the Association for Private Capital Investment in Latin America, a not-for-profit membership organization dedicated to supporting the growth of private capital in Latin America and the Caribbean through research, education, networking and advocacy.

    LAVCA Office

        New York City:
        589 8th Ave, 18th Floor
        New York, NY 10018

    Explore LAVCA.org

    • About LAVCA
    • Board, Team, & Advisors
    • Media
    • Contact Us
    • Membership Benefits
    • Members Only Access
    • Education and Programs
    • Research
    • Policy
    • LAVCA VC
    • Contact Us

    @2020 - LAVCA. All Rights Reserved.


    Back To Top